Hubungan antara Kepatuhan Penggunaan Obat Pasien Diabetes Mellitus Tipe 2 dengan Komplikasi Penyakit Jantung Korener
Kata Kunci:
Medication adherence, Diabetes mellitus, Coronary heart diseaseAbstrak
Diabetes mellitus (DM) is a well-established risk factor for coronary heart disease (CHD), making it a major public health problem worldwide. DM patients are two to four times more likely to develop CHD. Previous studies have shown that uncontrolled blood sugar levels may increase the risk of CHD. Therefore, adherence to medication is essential for patients with chronic diseases such as type 2 diabetes (T2DM). The aim of this study was to assess the association between medication adherence and complications of coronary heart disease. This was a retrospective case-control study using a dataset provided by Dr. Doris Silvanus Hospital in Palangka Raya. The sample was divided into two groups; one had CHD as a complication, while the other had no CHD complication. Sixty-three subjects were eligible for this study (21 with CHD complications and 42 with non-CHD complications). Statistical analysis showed that adherence to antidiabetic drugs had a significant (P-value < 0.001) and moderate (r = 0.538) correlation with CHD complications. In this study, adherence to diabetes medications was found to be significantly correlated with complications of coronary heart disease.
Referensi
Yosef T, Nureye D, Tekalign E. Poor glycemic control and its contributing factors among type 2 diabetes patients at Adama Hospital Medical College in East Ethiopia. Diabetes, Metabolic Syndrome and Obesity [Internet]. 2021 [cited 2025 May 17];3273–80. Available from: https://www.tandfonline.com/doi/full/10.2147/DMSO.S321756
Federation ID. IDF Diabetes Atlas Brussels. Belgium: international diabetes federation [Internet]. 2021 [cited 2025 May 17]; Available from: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/
Borse SP, Chhipa AS, Sharma V, Singh DP, Nivsarkar M. Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives. Medical Principles and Practice. 2021;30(2):109–21.
Nandasari NPW, Santhi DGDD, Yasa IWPS. Prevalensi gambaran faktor risiko penyakit jantung koroner pada pasien diabetes melitus tipe-2 di RSUP Sanglah Denpasar periode 2015. Intisari Sains Medis. 2020 Aug 1;11(2):484–8.
Muazizah C, Novida H. Faktor Risiko Kematian pada Pasien Diabetes Melitus dan Penyakit Jantung: Systematic Review. Jurnal Rumpun Ilmu Kesehatan. 2024 Jul 31;4(2):57–69.
Boonpattharatthiti K, Saensook T, Neelapaijit N, Sakunrag I, Krass I, Dhippayom T. The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy. 2024 Mar;20(3):255–95.
Hirakawa Y, Ninomiya T, Kiyohara Y, Murakami Y, Saitoh S, Nakagawa H, et al. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN). J Epidemiol. 2017 Mar;27(3):123–9.
Adisa R, B. Alutundu M, O. Fakeye T. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice (Internet). 2009 Sep;7(3).
Awodele O, Osuolale J. Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria. Afr Health Sci. 2015 May 28;15(2):513.
Ningrum DK. Kepatuhan Minum Obat pada Penderita Diabetes Melitus Tipe II. HIGEIA (Journal of Public Health Research and Development) [Internet]. 2020 [cited 2025 May 17];4(Special 3):492–505. Available from: https://journal.unnes.ac.id/sju/higeia/article/view/36231
Akrom A, Sari OM, Urbayatun S, Saputri Z. Analisis Determinan Faktor-Faktor yang Berhubungan dengan Kepatuhan Minum Obat Pasien Diabetes Tipe 2 di Pelayanan Kesehatan Primer. Jurnal Sains Farmasi & Klinis. 2019 May 29;6(1):54.
Kusuma IY. Pengaruh Usia Dan Jenis Kelamin Pada Kepatuhan Pasien Diabetes Melitus Menggunakan Obat Antidiabetes Di Perum Ketapang Sokaraja Kulon. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan. 2019 Jan 7;10(2):76–81.
Seo I, Suh SI, Suh MH, Baek WK. Genome-Wide Association Study of Medication Adherence in Chronic Diseases in the Korean Population. Genomics Inform. 2014;12(3):121.
Gonzalez JS, Tanenbaum ML, Commissariat P V. Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. American Psychologist. 2016 Oct;71(7):539–51.
Olagbemide OJ, Omosanya OE, Ayodapo AO, Agboola SM, Adeagbo AO, Olukokun TA. Family Support and Medication Adherence among Adult Type 2 Diabetes. Ann Afr Med. 2021 Oct;20(4):282–7.
Costa E, Giardini A, Savin M, Menditto E, Lehane E, Laosa O, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence [Internet]. 2015 [cited 2025 May 17];1303–14. Available from: https://www.tandfonline.com/doi/full/10.2147/PPA.S87551
Putri RG, Probosuseno P, Yasin NM. Narrative Review : Faktor yang Mempengaruhi Tingkat Kepatuhan Terapi pada Pasien Diabetes Melitus Tipe 2. Jurnal Surya Medika. 2024 Dec 15;10(3):309–14.
Della A, Subiyanto P, Maria A. Faktor-Faktor Yang Berhubungan Dengan Kepatuhan Pengobatan Pasien Diabetes Melitus Tipe 2. Jurnal Keperawatan Klinis dan Komunitas (Clinical and Community Nursing Journal). 2023 Jul 31;7(2):124.
Alqarni AM, Alrahbeni T, Qarni A Al, Qarni HM Al. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia–a cross-sectional survey. Patient Prefer Adherence [Internet]. 2018 [cited 2025 May 17];63–71. Available from: https://www.tandfonline.com/doi/full/10.2147/PPA.S176355
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol [Internet]. 2019 [cited 2025 May 17];11(3):45. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6628012/
Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J. 2006 Jul;152(1):27–38.
Kim YY, Lee JS, Kang HJ, Park SM. Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients. Sci Rep [Internet]. 2018 [cited 2025 May 17];8(1):12190. Available from: https://www.nature.com/articles/s41598-018-30740-y
Fox CS, Sullivan L, D’Agostino RB, Wilson PWF. The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality. Diabetes Care. 2004 Mar 1;27(3):704–8.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Prosiding Kedokteran dan Kesehatan
Artikel ini berlisensiCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
